IRCT138804091267N19已完成1 期
A phase I clinical trial on the use of autograft mesenchymal stem cells for treatment of diabetic chronic kidney disease
rology and Nephrology Research Center ( UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran, I.0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Presence of stage III diabetic nephropathy (GFR between 30 to 60 ml / min /1.73 m2), controlled hypertension, Blood creatinine level less than 2 mg/dl
- •Exclusion criteria: History or presence of psychological disorders, history or presence of previous immune deficiencies, consumption of immunosuppressive drugs, presence of renal artery stenosis
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Infusion of donor-derived CMV peptide-specific CTL after allogeneic HSCTImmune reconstitution post-allogeneic haematopoietic stem cell transplantationOther - Other blood disordersACTRN12605000213640Department of Haematology, Westmead Hospital12
已完成
1 期
se of stem cells for treatment of chronic kidney diseaseChronic Kidney Disease.Hypertensive renal diseaseIRCT201509031031N17Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell10
已完成
2 期
Effect of autograft/allograft combination of bone marrow stem cells and Schwann cells on complete chronic and subacute spinal cord injuries.Cronic and subacute spinal cord injuries.Injury of spinal cord, level unspecifiedT09.3IRCT20200502047277N8Shahid Beheshti University of Medical Sciences90
已完成
1 期
Phase I trial to assess safety of autologous Human Cytomegalovirus (HCMV) -specific T cell therapy for glioblastoma multiforme (GBM)Cancer - Brainglioblastoma multiformeACTRN12609000338268Queensland Institute of Medical Research10
终止
1 期
A clinical trial of adoptive T-cell immunotherapy for patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.Metastatic nasopharyngeal carcinomaCancer - Head and neckACTRN12613000866707QIMR Berghofer Medical Research Institute18